{
    "clinical_study": {
        "@rank": "144579", 
        "arm_group": [
            {
                "arm_group_label": "Parecoxib", 
                "arm_group_type": "Experimental", 
                "description": "Parecoxib"
            }, 
            {
                "arm_group_label": "Ketorolac", 
                "arm_group_type": "Experimental", 
                "description": "Ketorolac"
            }, 
            {
                "arm_group_label": "No medication", 
                "arm_group_type": "No Intervention", 
                "description": "No medication"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy of Parecoxib and Ketorolac as a\n      preemptive analgesia in patients undergoing lumbar spinal fusion."
        }, 
        "brief_title": "Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine Fusion", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Postoperative Pain", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "A prospective, double-blinded randomized control trial. Randomly allocated patient\n      undergoing posterior lumbar spinal fusion into 3 groups (n=32) to receive Parecoxib,\n      Ketorolac and Placebo around 30 minutes prior to incised skin. Efficacy was assessed by\n      visual analog scale score (0-10), total opioid consumption, complication and bleeding also\n      recorded."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing lumbar spinal fusion for one to three levels\n\n          -  ASA class I or II\n\n        Exclusion Criteria:\n\n          -  History of allergy to Sulfa group\n\n          -  History of allergy to OPOID or NSAIDs\n\n          -  Contraindicate to NSAIDs use\n\n          -  History of coagulopathy or platelet disfunction"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01859585", 
            "org_study_id": "PSU-0001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Parecoxib", 
                "description": "Parecoxib 40 mg intravenous", 
                "intervention_name": "Parecoxib", 
                "intervention_type": "Drug", 
                "other_name": "Dynastat"
            }, 
            {
                "arm_group_label": "Ketorolac", 
                "description": "Ketorolac 30 mg intravenous", 
                "intervention_name": "Ketorolac", 
                "intervention_type": "Drug", 
                "other_name": "Ketolac"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Ketorolac", 
                "Ketorolac Tromethamine", 
                "Parecoxib"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "preemptive analgesia", 
            "lumbar fusion", 
            "Parecoxib", 
            "Ketorolac"
        ], 
        "lastchanged_date": "May 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hadyai", 
                    "country": "Thailand", 
                    "state": "Sonkla", 
                    "zip": "90110"
                }, 
                "name": "Faculty of Medicine, Prince of Songkla University"
            }
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "3", 
        "official_title": "Comparing the Efficacy of Parecoxib and Ketorolac as Preemptive Analgesia in Patients Undergoing Posterior Lumbar Spinal Fusion", 
        "other_outcome": {
            "measure": "Amount of drain output and Other Adverse effect", 
            "safety_issue": "Yes", 
            "time_frame": "7 days postoperatively"
        }, 
        "overall_official": {
            "affiliation": "Orthopedic Department, Faculty of Medicine, Prince of Songkla University, Songkla, Thailand", 
            "last_name": "Koopong Siribumrungwong, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Thailand: Ethical Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "recorded as Verbal Numerical Rating Scare 0-10", 
            "measure": "Pain score", 
            "safety_issue": "Yes", 
            "time_frame": "Postoperative time up to 24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01859585"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Prince of Songkla University", 
            "investigator_full_name": "KOOPONG SIRIBUMRUNGWONG, MD", 
            "investigator_title": "Comparing the efficacy of Parecoxib and Ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Total amount of opioid consumption postoperatively", 
            "safety_issue": "Yes", 
            "time_frame": "Postoperative 24 hours"
        }, 
        "source": "Prince of Songkla University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Prince of Songkla University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}